We are live on ! Find out more
MOR

MorphoSys AG American Depositary Shares

Delisted

MOR was delisted on the 2nd of August, 2024.

24 hedge funds and large institutions have $52M invested in MorphoSys AG American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $43.6M → $52M (+$8.38M)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

11% less funds holding

Funds holding: 2724 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2K

Holders
24
Holders Change
-3
Holders Change %
-11.11%
% of All Funds
0.38%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
9
Reduced
9
Closed
5
Calls
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
T. Rowe Price Investment Management
1
T. Rowe Price Investment Management
Maryland
$30M +$1.39M +315,037 +4%
LGM
2
Logos Global Management
California
$5.94M +$2.64M +600,000 +67%
OM
3
Opaleye Management
Massachusetts
$4.73M +$1.31M +297,400 +33%
Millennium Management
4
Millennium Management
New York
$4.04M +$878K +199,202 +24%
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$3.4M -$220K -50,000 -5%
AA
6
AlphaCentric Advisors
Puerto Rico
$731K
Morgan Stanley
7
Morgan Stanley
New York
$576K -$15.1K -3,425 -2%
TD Asset Management
8
TD Asset Management
Ontario, Canada
$562K
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$557K +$619K +140,428 +70,214%
Optiver Holding
10
Optiver Holding
Netherlands
$482K +$262K +59,558 +95%
TCM
11
Tekla Capital Management
Massachusetts
$323K
CS
12
Candriam SCA
Luxembourg
$212K
KI
13
Kapitalo Investimentos
Brazil
$136K +$152K +34,457 New
Goldman Sachs
14
Goldman Sachs
New York
$120K +$1.76K +399 +1%
TSS
15
Two Sigma Securities
New York
$86.1K +$95.7K +21,730 New
BlackRock
16
BlackRock
New York
$84.3K -$10.7K -2,436 -10%
Bank of America
17
Bank of America
North Carolina
$9.83K +$700 +159 +7%
UBS Group
18
UBS Group
Switzerland
$9.5K +$6.86K +1,557 +185%
US Bancorp
19
US Bancorp
Minnesota
$8.81K -$405 -92 -4%
LC
20
Lindbrook Capital
California
$4.56K -$1.3K -296 -20%
S
21
SignatureFD
Georgia
$602 -$3.23K -732 -83%
BNP Paribas Financial Markets
22
BNP Paribas Financial Markets
France
$395 -$441 -100 -50%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$47 -$956K -217,028 -100%
Barclays
24
Barclays
United Kingdom
$12 -$40 -9 -75%
ABG
25
Ally Bridge Group
New York
-$1.45M -405,602 Closed

MOR Hedge Fund Activity: Q1 2023 in Review

24 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q1 2023, worth a combined $52M — up 19% from $43.6M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of MOR and 2 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Logos Global Management, adding an estimated $2.64M. The largest seller was Ally Bridge Group, exiting entirely with an estimated $1.45M sold.

  • 24 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q1 2023, down from 27 in Q4 2022.
  • Funds reported $52M of MorphoSys AG American Depositary Shares stock for Q1 2023, up 19% quarter-over-quarter.
  • 2 funds opened new MorphoSys AG American Depositary Shares positions in Q1 2023 and 5 closed out, a net change of -3 holders.
  • The largest MorphoSys AG American Depositary Shares buyer in Q1 2023 was Logos Global Management, an estimated $2.64M added.
  • The largest MorphoSys AG American Depositary Shares seller in Q1 2023 was Ally Bridge Group, an estimated $1.45M sold.

Based on aggregated 13F filings for Q1 2023.